A new oral contraceptive based on the normophasic method
Bolle, J.; Poulain, A.
Arzneimittel-Forschung 26(3): 441-443
1976
ISSN/ISBN: 0004-4172 PMID: 989342 Document Number: 429354
A trial involved 62 women for over 554 cycles during which time a new normophasic oral contraceptive, Fisioquens, was administered. The preparation was tested with particular reference to the following parameters: contraceptive reliability, cycle control, frequency of possible side effects, and drug tolerance. A treatment cycle consisted of 7 tablets of .05 mg ethinyl estradiol followed by 15 tablets of a combination .05 mg ethinyl estradiol and 1 mg lynestrenol. Pregnancies were absent and irregular bleeding occurred sporadically. Various side effects diminished during treatment. The number of dropouts which could probably be attributed to the preparation itself was 4 (6.4%). These data indicate that Fisioquens appears to be a reliable contraceptive with a minimum number of side effects.